Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2025. The report documents the convening of the Company's Annual and Special General Meeting of Shareholders held on August 20, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance proceedings rather than financial performance data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this document. The primary event reported is the successful shareholder vote on all agenda items outlined in the Proxy Statement filed on July 16, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It confirms that a quorum was present and that shareholders approved all agenda items by the required majority. The report is incorporated by reference into the Company's Registration Statements on Form F-3 and Form S-8.
Investor Verification Checklist
- Verify the specific agenda items approved by shareholders by reviewing the Proxy Statement filed on July 16, 2025 (Exhibit 99.2).
- Confirm the quorum status and voting results for the August 20, 2025 meeting.
- Review the referenced Registration Statements (Form F-3 and Form S-8) for updated financial data not included in this 6-K.